Psilocybin and creative work — an artist's report after 8 sessions
I'm a visual artist. Over three years I've integrated psilocybin into my creative practice at various doses. Here's an honest accounting.
I'm a painter. I've been incorporating psilocybin into my practice — not every session, not as a formula — but as a tool I've learned to use with some intentionality over about three years and eight sessions at various doses.
What I can say honestly about what it's done to my work:
Permission: The most consistent effect isn't visual complexity — it's permission. Under psilocybin I'm willing to make marks I'd otherwise reject as too much, too strange, too risky. Many of the works in my current series started as session sketches made in the hours after, while perceptual novelty was still available. The internal critic is quieter, not absent.
Perceptual effects: At 2g, colors become more saturated and surfaces have a quality of aliveness that I've tried to approximate in painting ever since. The patterning effects — the fractal nature of visual experience under psilocybin — have directly influenced how I approach texture. Not that I paint fractals; I paint the quality of attention that sees the world as alive with pattern.
Slower doses, slower results: I tried microdosing (0.1g) while actually painting. It didn't do much. For me the productive zone is 1.5-2.5g, taken early in the day, with painting happening in the late afternoon after the peak has passed and perceptual subtlety remains. Working during the peak itself is too disorienting for me — I can't judge what I'm making.
The integration problem: There's a temptation to use psilocybin as a crutch — to feel like your good work depends on it. I've consciously limited my sessions for this reason. The insights should feed sober practice, not replace it.
More Experience Reports
Three years of talk therapy, one psilocybin session, and a fundamentally different relationship with anxiety. A first-timer's account of a licensed Oregon session.
Read →What happens when you underestimate a potent strain. A first-person account of a difficult experience, how the STOP protocol made the difference, and what emerged from the center of it.
Read →A Marine veteran with treatment-resistant PTSD reflects 60 days after participating in a university psilocybin clinical trial. The session didn't cure anything. But the relationship changed.
Read →